In this study, we report on the identification and characterization of small-molecule MMRi62 as an MDM4 degrader and a p53-independent apoptosis inducer with the potential to overcome daunorubicin resistance in p53 null leukemia cells. This evidence concerns the gene TP53 and leukemia.